Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | IKBKB | O14920 | 1/20 | 0.32 |
| ▸ | CHUK | O15111 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22062742 | 0.86 | KDM4E (0.38) | KDM4EALDH1A1LMNA | |
| SCHEMBL22063269 | 0.86 | MAPT (0.37) | KDM4EALDH1A1LMNA | |
| SCHEMBL22063137 | 0.86 | KDM4E (0.43) | KDM4EALDH1A1LMNAIKBKBCHUK | |
| SCHEMBL22063141 | 0.84 | KDM4E (0.34) | KDM4EALDH1A1LMNAIKBKBCHUK | |
| SCHEMBL22087428 | 0.83 | KDM4E (0.37) | KDM4EALDH1A1LMNAIKBKBCHUK | |
| SCHEMBL22063249 | 0.83 | KDM4E (0.36) | KDM4EALDH1A1LMNA | |
| SCHEMBL22063251 | 0.83 | KDM4E (0.36) | KDM4EALDH1A1LMNAIKBKBCHUK | |
| SCHEMBL22063268 | 0.82 | AHR (0.33) | KDM4EALDH1A1 | |
| SCHEMBL22062741 | 0.82 | KDM4E (0.40) | KDM4EALDH1A1LMNAIKBKBCHUK | |
| SCHEMBL22062588 | 0.81 | TLR8 (0.33) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | EMC2, NFE2L2, AOC2 | KDM4E 1152/4885ALDH1A1 1970/4885LMNA 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.